Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
ProShares VIX Short-Term Futures ETF (VIXY): What to Know About This Volatility Exposure Tool

ProShares VIX Short-Term Futures ETF (VIXY): What to Know About This Volatility Exposure Tool

Key Takeaways

  • VIXY is an exchange-traded fund (ETF) issued by ProShares that seeks to track the S&P 500 VIX Short-Term Futures Index.
  • It provides exposure to futures contracts tied to the Cboe Volatility Index (VIX), a widely followed gauge of expected stock market volatility.
  • The fund is designed as a short-term hedging or tactical trading tool, not a long-term buy-and-hold investment.
  • VIXY has an expense ratio of 0.85% and was launched on January 3, 2011.
  • Because it holds volatility futures that are continuously rolled, the fund is subject to "contango," which can create a persistent drag on returns over time.

Introduction

The ProShares VIX Short-Term Futures ETF (VIXY) offers investors a way to gain exposure to short-term volatility futures. It centers on the Cboe Volatility Index, or VIX, which tracks expected near-term volatility in the S&P 500. Investors often look to VIXY as a potential hedge during equity market downturns or as a tactical way to position for shifts in market uncertainty. I also checked this using Tickeron’s AI Screener to see how the fund compares to other volatility-linked products.

ETF Overview

VIXY's objective is to deliver results that, before fees and expenses, match the performance of the S&P 500 VIX Short-Term Futures Index. This benchmark reflects returns from a portfolio of monthly VIX futures contracts, with daily rolls from first-month into second-month contracts to keep an average one-month time to expiration. The VIX itself cannot be held directly since it is a calculated index based on S&P 500 options prices. Instead, VIXY uses VIX futures contracts that reflect market expectations for the VIX at future dates. The fund is passively managed to replicate its benchmark.

Issuer, Launch and Structure

ProShares issues VIXY, a firm known for geared and thematic ETFs that include leveraged, inverse, and volatility products. The fund launched on January 3, 2011, and was one of the early volatility offerings structured as an ETF rather than an ETN. One key detail is that VIXY operates as a commodity pool partnership. This structure means it issues K-1 tax forms, with gains and losses typically marked to market each year, which differs from standard ETF tax treatment.

Portfolio Holdings and Allocation

VIXY's holdings center on near-term VIX futures contracts, with the rest in cash or cash equivalents to support those positions. The narrow focus means only a small number of holdings at any time, typically the front-month and second-month VIX futures. From what I see, this concentrated approach keeps the fund tightly aligned with short-term volatility moves.

Costs and Rebalancing

The net expense ratio stands at 0.85%. The fund does not pay dividends. Its index rebalances daily through futures rolls that maintain an average one-month maturity. This daily process means VIXY targets day-to-day index tracking rather than longer-term performance.

Why Investors Follow VIXY

VIXY draws interest because of its link to volatility. Equity market declines often push the VIX higher, and instruments tied to VIX futures can rise sharply in response. This positions VIXY as a consideration for hedging equity exposure or taking a short-term view on rising uncertainty. One thing that stands out is its historically negative correlation to stocks, which can provide a diversification effect during stress periods. I’m watching this closely as volatility often signals broader market sentiment shifts.

Risks and Important Considerations

VIXY carries risks unlike those of typical stock or bond ETFs. Contango is the primary issue, where longer-dated VIX futures trade at higher prices than near-term ones. Continuous rolling into more expensive contracts can erode value even if the VIX stays flat. Additional factors include single-asset-class concentration, the daily reset feature, and the expense ratio that can amplify contango effects. The partnership structure and K-1 reporting add further complexity. In my view, this makes VIXY best suited for short-term tactical or hedging use rather than long-term holding.

Using Tickeron’s AI Tools for Research

When analyzing funds like VIXY, I often turn to Tickeron’s AI Screener to quickly compare volatility products across technical indicators, fundamentals, and custom filters. It helps surface ideas that align with a specific strategy without sifting through thousands of securities manually. This kind of tool has become a regular part of my process for understanding how different ETFs behave in various market conditions.

Conclusion

The ProShares VIX Short-Term Futures ETF (VIXY) serves as a specialized instrument distinct from standard equity or bond funds. Its focus on short-term VIX futures provides a liquid way to express views on volatility or hedge equity positions. At the same time, futures rolling and contango create structural challenges that favor short-term use over long-term investing. Reviewing the strategy, holdings, and costs remains essential before including VIXY in any portfolio.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VIXY

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


Momentum Indicator for VIXY turns positive, indicating new upward trend

VIXY saw its Momentum Indicator move above the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In 73 of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for VIXY just turned positive on November 16, 2026. Looking at past instances where VIXY's MACD turned positive, the stock continued to rise in 42 of 47 cases over the following month. The odds of a continued upward trend are 89%.

VIXY moved above its 50-day moving average on November 12, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VIXY crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.

Following a +17.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIXY advanced for three days, in 163 of 189 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 66 of 74 cases where VIXY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIXY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

VIXY broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks investment results, before fees and expenses, that over time, match the performance of the S&P 500 VIX Short-Term Futures Index for a single day. The index seeks to offer exposure to market volatility through publicly traded futures markets and is designed to measure the implied volatility of the S&P 500 over 30 days in the future.
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.